期刊文献+

亚硒酸钠对K562/ADR细胞系VEGF表达的影响 被引量:1

Effects of Na_2SeO_3 on Expression of VEGF in K562/ADR Cells
下载PDF
导出
摘要 为了探讨亚硒酸钠对K562/ADR细胞VEGF表达的影响,分别以5、10μmol/L的亚硒酸钠对培养的K562及K562/ADR细胞进行处理,应用ELISA法检测亚硒酸钠处理前和处理后不同时间的K562及K562/ADR细胞上清液中VEGF含量,用MTT法检测逆转耐药倍数。结果表明:亚硒酸钠可以增加K562/ADR细胞对阿霉素的敏感性,其逆转耐药的倍数为3.48倍;两种细胞系分泌的VEGF含量随培养时间的延长增加,并且各个时间段的K562/ADR细胞VEGF表达均高于K562细胞(P<0.05);5、10μmol/L的亚硒酸钠在72小时内均不能抑制K562细胞VEGF的分泌(P>0.05);而作用96小时时K562细胞上清液中VEGF水平虽有下降,但未达统计学意义;5、10μmol/L的亚硒酸钠在48小时内均不能抑制K562/ADR细胞VEGF的分泌(P>0.05),10μmol/L的亚硒酸钠在作用72和96小时可以明显抑制VEGF的分泌(P<0.001),5μmol/L的亚硒酸钠在作用96小时可以抑制VEGF的分泌(P<0.001)。结论:VEGF可能与白血病多药耐药有关,而亚硒酸钠则能抑制白血病细胞分泌VEGF。 In order to investigate the effects of Na2SeO3 on expression of VEGF in K562/ADR cells, K562 and K562./ ADR cells were treated with Na2SeO3 at dose of 5 and 10 μmol/L. The expressions of VEGF in K562 and K562/ADR cells were detected by ELISA before and at the different time point after treatment. The mutiplie of reversion of resistance was detected by MTT method. The results showed that Na2SeO3 at dose of 10 μmol/L could increase the sensitivity of K562/ADR cell to adriamycin, the multiple of reversion was 3.48. The expression levels of VEGF in K562 and K562/ADR cells increased with prolongation of time cultured, and the VEGF expression levels in K562/ADR cells at the different time points were higher than that in K562 cells ( P 〈0.05 ) ; 5 and 10 μmol/L Na2SeO3 did not suppress expression of VEGF in K562 cells at 72 hours (P 〉 0. 05 ), and the VEGF level in K562 cells at 96 hours decreased without statistical significance; 5 and 10 μmol/L Na2SeO3 acting for 48 hours did not show suppressive effect on expression of VEGF in K562/ADR cells ( P 〉 0.05 ), 5 μmol/ L Na2SO3 could decrease the expression of VEGF in K56Z/ADR cell after treatment for 96 hours, while 10 μmol/L Na2SeO3 could significantly decrease the expression of VEGF in K562/ADR cells treated for 72 hours and 96 hours ( P 〈0.01 ). It is concluded that VEGF would be involved in the multidrug resistance of leukemia. Na2SeO3 decreasing expression of VEGF in leukemic cells may be one of the mechanisms reversing multidrug resistance.
出处 《中国实验血液学杂志》 CAS CSCD 2007年第3期474-477,共4页 Journal of Experimental Hematology
关键词 亚硒酸钠 白血病 血管内皮生长因子 K562细胞 ADR细胞 耐药 Na2SeO3 Leukemia VEGF K562 cell ADR cell drug resistance
  • 相关文献

参考文献5

二级参考文献52

  • 1[1]Salven P, Teerenhovi L, Joensuu H. A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma [J].Blood, 1999,94:3334 - 3339.
  • 2[2]Neben K, Moehler T, Egerer G, et al. High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma [J]. Clin Cancer Res,2001,7(9): 2675 - 2681.
  • 3[3]Molica S, Vitelli G, Levato D, et al. Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia [J] . Br J Haematol,1999, 107:605 - 610.
  • 4[4]Gerber HP, Ferrara N. The role of VEGF in normal and neoplastic hematopoiesis [J]. J Mol Med,2003, 81: 20- 31.
  • 5[5]de Bont ES, Rosati S, Jacobs S, et al. Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor [J]. BrJ Haematol,2001,113 (2): 296 - 304.
  • 6[6]Allouche M, Bayard F, Clamens S, et al. Expression of basic fibroblast growth factor (bFGF) and FGF-receptors in human leukemic cells [J]. Leukemia, 1995, 9:77 - 86.
  • 7[7]Molica S, Vitelli G, Levato D, et al. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression [J]. Eur J Haematol, 2004, 73:36 - 42.
  • 8Folkman J. Tumor angiogenesis: therapeutic implications. New Engl J Med, 1971; 285:1182- 1186.
  • 9Cohen T, Nahari D, Cerem LW, et al. lnterleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem,1996; 271:736 - 741.
  • 10Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med,1991; 324:1-8.

共引文献18

同被引文献31

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部